These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 24605827)

  • 1. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
    Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H
    Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice.
    Tamura Y; Kawao N; Yano M; Okada K; Okumoto K; Chiba Y; Matsuo O; Kaji H
    Diabetes; 2015 Jun; 64(6):2194-206. PubMed ID: 25552599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.
    Ma LJ; Mao SL; Taylor KL; Kanjanabuch T; Guan Y; Zhang Y; Brown NJ; Swift LL; McGuinness OP; Wasserman DH; Vaughan DE; Fogo AB
    Diabetes; 2004 Feb; 53(2):336-46. PubMed ID: 14747283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency.
    Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G
    J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-fat Diet Enhances and Plasminogen Activator Inhibitor-1 Deficiency Attenuates Bone Loss in Mice with Lewis Lung Carcinoma.
    Yan L; Nielsen FH; Sundaram S; Cao J
    Anticancer Res; 2015 Jul; 35(7):3839-47. PubMed ID: 26124329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
    Bouter B; Geary N; Langhans W; Asarian L
    Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.
    Morange PE; Lijnen HR; Alessi MC; Kopp F; Collen D; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1150-4. PubMed ID: 10764686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice.
    Takafuji Y; Tatsumi K; Ishida M; Kawao N; Okada K; Matsuo O; Kaji H
    J Cell Physiol; 2019 Jun; 234(6):9687-9697. PubMed ID: 30387130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Obesity and insulin resistance syndrome].
    Tokunaga K; Matsuzawa Y
    Nihon Rinsho; 1996 Oct; 54(10):2679-86. PubMed ID: 8914427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST; Ataç FB; Verdi H; Cetintaş S; Sahin FI; Ozbek N
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.
    Lijnen HR
    Thromb Haemost; 2005 May; 93(5):816-9. PubMed ID: 15886793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy-restricted diet benefits body composition but degrades bone integrity in middle-aged obese female rats.
    Shen CL; Zhu W; Gao W; Wang S; Chen L; Chyu MC
    Nutr Res; 2013 Aug; 33(8):668-76. PubMed ID: 23890357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of plasminogen activator inhibitor-1 deficiency on bone disorders and sarcopenia caused by adenine-induced renal dysfunction in mice.
    Mizukami Y; Kawao N; Ohira T; Okada K; Yamao H; Matsuo O; Kaji H
    PLoS One; 2024; 19(10):e0311902. PubMed ID: 39388484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAI-1 gene 4G/5G polymorphism, cytokine levels and their relations with metabolic parameters in obese children.
    Kinik ST; Ozbek N; Yuce M; Yazici AC; Verdi H; Ataç FB
    Thromb Haemost; 2008 Feb; 99(2):352-6. PubMed ID: 18278185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity.
    Zaman AK; Fujii S; Goto D; Furumoto T; Mishima T; Nakai Y; Dong J; Imagawa S; Sobel BE; Kitabatake A
    J Mol Cell Cardiol; 2004 Aug; 37(2):525-35. PubMed ID: 15276022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.
    Nordstrom SM; Carleton SM; Carson WL; Eren M; Phillips CL; Vaughan DE
    Bone; 2007 Dec; 41(6):995-1004. PubMed ID: 17888748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity?
    Bastard JP; Bruckert E; Robert JJ; Ankri A; Grimaldi A; Jardel C; Hainque B
    Int J Obes Relat Metab Disord; 1995 Nov; 19(11):836-8. PubMed ID: 8589788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator inhibitor-1 deficiency has renal benefits but some adverse systemic consequences in diabetic mice.
    Collins SJ; Alexander SL; Lopez-Guisa JM; Cai X; Maruvada R; Chua SC; Zhang G; Okamura DM; Matsuo S; Eddy AA
    Nephron Exp Nephrol; 2006; 104(1):e23-34. PubMed ID: 16735799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.